Both in Biotechnology
Armata Pharmaceuticals vs Neumora Therapeutics
Over the past year ARMP returned −35.1% and NMRA returned −79.7%; their daily moves had a correlation of 0.20.
ARMP −35.1% NMRA −79.7%Growth of $1, one year, split-adjusted
| Metric | ARMP | NMRA |
|---|---|---|
| Price | $3.14 | $0.5660 |
| Market cap | $116.8M | $106.3M |
| Today | +1.62% | −0.86% |
| 1 month | −18.4% | +20.2% |
| 6 months | −65.3% | −75.7% |
| Year to date | −50.0% | −68.4% |
| 1 year | −35.0% | −81.2% |
| Revenue growth (YoY) | +15.7% | — |
| Gross margin | 100.0% | — |
| Net margin | 2953.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 21.1× | — |
| Net cash | -$259.6M | $63.9M |
| Dividend yield | — | — |
| Volatility (60d) | 114.9% | 125.6% |
| Short % of float | 4.4% | 6.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).